Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(2):170-182
For the first time in Russian economic conditions and with use of mathematic modeling, clinical-economic study of posaconazole in comparison with fluconazole/itraconazole for primary prophylaxis of invasive mycoses in patients with severe neutropenia …